Login

Reggie Groves, CEO, REVA Medical Inc 00:00:00

Share On Facebook Share On Twitter

Reva develops bioresorbable coronary scaffolds for the treatment of cardiovascular disease.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
How his company makes MicroStation easier|David Greenbaum,Founder and CEO,Axiom's
00:10:00
Grove Point Investments, LLC, a member of FINRA/SIPC, provides investment services, while its affiliate, Grove Point Advisors, LLC, offers advisory services.
00:10:00
Our scientists set the pace We have been the gold standard in bioscience for more than 120 years|Paula Volent,CIO,Rockefeller University Endowment
00:10:00
CEO Andreas Morfiadakis Discusses KlaraBo's Q1 Performance in Live Interview | Andreas Morfiadakis, CEO, KlaraBo Sverige AB.
00:10:00
solve problems and multiply the benefits of capitalism for everyone while reducing its cost|Dr. Kiersten Stead,Managing Partner, DCVC Bio,DCVC
00:10:00
Robert Ogór on AMBRA SA's Wine Market Strategy and Increased Dividend Expectations | Robert Ogór, President, AMBRA SA.
00:10:00
For digital mining solutions, Orica introduces Axis Mining Technology. | Shane Munyard, CEO, Axis Mining Technology Pty Ltd. (TS)
00:10:00
Scott Morris, presidente e CEO da Avista, representou a empresa como Parceira do Ano no Red Tie Gala de 2018.
00:10:00
Inside Danieli's New Innovation Center
00:10:00
Embracing the Torture You Love for Success
00:10:00
Mandalay Resources Highlights Production Growth and Exploration Potential at One-to-One Mining Investment Conference
00:10:00
Supporting the world's best health tech founders|Austin Walters,Founder and Managing Partner,SpringTide Ventures

© 2017 - Neuhu+